These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7366965

  • 1. [Experience with combined drug therapy of Hodgkin's disease, using chlorambucil, vinblastine, procarbazine and prednisolone].
    Berényi E, Dankó K, Szegedi G.
    Orv Hetil; 1980 Mar 17; 121(10):571-3. PubMed ID: 7366965
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Drug therapy of Hodgkin's disease].
    Gallmeier WM, Bruntsch U.
    Internist (Berl); 1981 May 17; 22(5):289-300. PubMed ID: 7019138
    [No Abstract] [Full Text] [Related]

  • 4. [Changes of serum amino acids during polychemotherapy in Hodgkin's disease].
    Tilz GP, Stübchen-Kirchner H, Sailer S.
    Wien Med Wochenschr; 1974 Oct 19; 124(42-43):617-9. PubMed ID: 4439956
    [No Abstract] [Full Text] [Related]

  • 5. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
    Dady PJ, McElwain TJ, Austin DE, Barrett A, Peckham MJ.
    Br J Cancer; 1982 Jun 19; 45(6):851-9. PubMed ID: 7093120
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapeutic implications of staging in Hodgkin's disease.
    DeVita VT, Carbone PP.
    Cancer Res; 1971 Nov 19; 31(11):1838-44. PubMed ID: 4941352
    [No Abstract] [Full Text] [Related]

  • 7. OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's disease.
    Barnett MJ, Man AM, Richards MA, Waxman JH, Wrigley PF, Lister TA.
    Hematol Oncol; 1987 Nov 19; 5(2):79-82. PubMed ID: 3596472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Progress in combination chemotherapy of malignant lymphomas (author's transl)].
    Senn HJ.
    Schweiz Rundsch Med Prax; 1973 Dec 18; 62(51):1589-94. PubMed ID: 4771027
    [No Abstract] [Full Text] [Related]

  • 13. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW, Maurice P, Sonntag RW.
    Schweiz Med Wochenschr; 1972 Oct 28; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute leukemia in Hodgkin's disease.
    Sahakian GJ, al-Mondhiry H, Lacher MJ, Connolly CE.
    Cancer; 1974 May 28; 33(5):1369-75. PubMed ID: 4132698
    [No Abstract] [Full Text] [Related]

  • 18. [N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis].
    Vermel' AE, Korman NP, Magagina GE, Raevskiĭ IG.
    Vopr Onkol; 1974 May 28; 20(3):8-13. PubMed ID: 4439805
    [No Abstract] [Full Text] [Related]

  • 19. [Polychemotherapy in generalized form of Hodgkin's disease].
    van Hove W, Hamers J, Baele G, Vermeulen A.
    Acta Clin Belg; 1975 May 28; 30(4):277-82. PubMed ID: 1211048
    [No Abstract] [Full Text] [Related]

  • 20. [Use of combined cystostatic therapy in the late stage of Hodgkin's disease].
    Berényi E.
    Orv Hetil; 1976 May 30; 117(22):1337-40. PubMed ID: 934630
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.